Skip to main content
. 2021 Apr 5;16(4):e0248471. doi: 10.1371/journal.pone.0248471

Table 1. Baseline patient characteristics & prevalence of comorbidities in the study sample.

Baseline characteristics (n = 1852)
  mean (SD) or %
Men n (%) 52%
Age (years) 64.1 (13.0)
BMI (kg/m2) 27.6 (4.7)
BMI ≥25 kg/m2 70%
BMI ≥30 kg/m2 26%
SBP 153.0 (12.4)
DBP 88.5 (9.4)
AHD treatment duration 8.4 (6.3)
Good adherence (%) 62%
Moderate adherence (%) 34%
Bad adherence (%) 4%
Grade 1 HT (%) 60%
Grade 2 HT (%) 33%
Grade 3 HT (%) 7%
ISHT (%) 41%
IDHT (%) 3%
S & D HT (%) 56%
Dyslipidaemia 61%
Diabetes 33%
Prior CV event 22%
Peripheral vascular disease 13%
Arrhythmias 13%
Renal Failure 8%
Heart Failure 5%
Other comorbidity 12%
None 3%
≥ 3 Comorbidities (%) 16%

Abbreviations: SD: Standard deviation; BMI: Body Mass Index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; AHD: Antihypertensive drug; HT: Hypertension; ISH: Isolated systolic hypertension; IDHT: Isolated diastolic hypertension; S & D HT: Systolic and diastolic hypertension.